- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 3.21M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.21M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 3.16M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$12.99M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$13.85M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $33.34M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $46.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $18.76M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $46.71M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $61.26M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $20.1M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $23.08M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $24.71M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $43.53M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $34.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $47.76M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $36.46M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $62.28M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.36 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$4.87 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.36 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$4.87 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.79M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $6.09M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $4.09M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $7.74M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7.56M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$15.41M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.25M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$16.46M |